ACIXF vs ABT: Which Stock is Better?
Side-by-side comparison of Acarix AB (publ) and Abbott Laboratories in 2026
ACIXF
Acarix AB (publ)
$0.03
ABT
Abbott Laboratories
$121.14
Key Metrics Comparison
| Metric | ACIXF | ABT | Winner |
|---|---|---|---|
| Market Cap | $36.42M | $210.84B | ABT |
| P/E Ratio | N/A | 15.22 | ABT |
| EPS (TTM) | $N/A | $7.96 | ABT |
| Revenue Growth | 1.4% | 0.1% | ACIXF |
| Gross Margin | 86.2% | 56.3% | ACIXF |
Analyze ACIXF
Full quant analysis
Analyze ABT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACIXF or ABT a better investment?
Comparing ACIXF and ABT: Acarix AB (publ) has a market cap of $36.42M while Abbott Laboratories has $210.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACIXF and ABT?
ACIXF (Acarix AB (publ)) and ABT (Abbott Laboratories) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACIXF or ABT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ACIXF or ABT?
ACIXF has higher revenue growth at 1.4% vs 0.1% for ABT.
Which company is more profitable: ACIXF or ABT?
Acarix AB (publ) (ACIXF) has higher gross margins at 86.2% compared to 56.3% for ABT.
Which is the larger company: ACIXF or ABT?
Abbott Laboratories (ABT) is larger with a market cap of $210.84B compared to $36.42M for ACIXF.
Should I buy ACIXF or ABT in 2026?
Both ACIXF and ABT have investment merit. ACIXF trades at $0.03 while ABT trades at $121.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACIXF and ABT stock?
Key differences: Market Cap ($36.42M vs $210.84B), P/E Ratio (N/A vs 15.2x), Revenue Growth (1.4% vs 0.1%), Gross Margin (86.2% vs 56.3%).